Skip to content
Screener

Medtronic MDT EV / EBITDA

EV / EBITDA at other companies

Abbott logo
AbbottABT
17.2×-6.0×
TFX
TeleflexTFX
26.8×+7.6×
Johnson & Johnson logo
Johnson & JohnsonJNJ
19×+5.2×
Stryker logo
StrykerSYK
22.1×-11.8×
Artivion logo
ArtivionAORT
32.2×-2.2×
CONMED logo
CONMEDCNMD
12.2×+1.1×

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$109.3B-4.8%
Enterprise value$136.56B-4.0%
P/E22.8×-1.9×
P/S-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Calculated from Medtronic’s reported figures.

Based on the most recent quarter.

The source filing: Medtronic’s 10-K, filed June 18, 2026. Open the filing →

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354

FAQ

What is Medtronic's EV / EBITDA?
Medtronic (MDT) reported EV / EBITDA of 13.9× in Q1 2026.
How has Medtronic's EV / EBITDA changed year-over-year?
Medtronic's EV / EBITDA decreased by 9.5% year-over-year, from 15.4× to 13.9×.
What is the long-term trend for Medtronic's EV / EBITDA?
Over 5 years (2021 to 2026), Medtronic's EV / EBITDA has grown at a -12.9% compound annual growth rate (CAGR), from 27.8× to 13.9×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Medtronic's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude